Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
18 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/18/2948213/0/en/Pharmacosmos-Group-and-G1-Therapeutics-Announce-Successful-Closing-of-Tender-Offer.html
05 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/05/2941161/0/en/Pharmacosmos-Group-and-G1-Therapeutics-Announce-Expiration-of-Hart-Scott-Rodino-Waiting-Period.html
08 Aug 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/pharmacosmos-picks-g1-therapeutics-and-its-cosela-merger-worth-405m
08 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/08/2926725/0/en/G1-Therapeutics-Provides-Second-Quarter-2024-Financial-Results-and-Operational-Highlights.html
01 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/01/2923330/0/en/G1-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
25 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/25/2918990/0/en/G1-Therapeutics-to-Release-Second-Quarter-2024-Financial-Results-and-Provide-Business-Update-on-August-8-2024.html
ABOUT THIS PAGE
G1 Therapeutics, Inc is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Trilaciclib Dihydrochloride bulk offered by G1 Therapeutics, Inc